141 related articles for article (PubMed ID: 37722495)
1. The use of liposomes functionalized with the NFL-TBS.40-63 peptide as a targeting agent to cross the in vitro blood-brain barrier and target glioblastoma cells.
Mellinger A; Lubitz LJ; Gazaille C; Leneweit G; Bastiat G; Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2023 Nov; 646():123421. PubMed ID: 37722495
[TBL] [Abstract][Full Text] [Related]
2. Investigating the functionalization of liposomes with NFL-TBS. 40-63 peptide as a promising drug delivery system.
Jourdain MA; Dupont A; Lautram N; Eyer J
Int J Pharm; 2024 Mar; 652():123805. PubMed ID: 38237710
[TBL] [Abstract][Full Text] [Related]
3. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
[TBL] [Abstract][Full Text] [Related]
4. Effect of the NFL-TBS.40-63 peptide on canine glioblastoma cells.
Audrey G; Claire LC; Joel E
Int J Pharm; 2021 Aug; 605():120811. PubMed ID: 34144141
[TBL] [Abstract][Full Text] [Related]
5. The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2013 Oct; 454(2):738-47. PubMed ID: 23603097
[TBL] [Abstract][Full Text] [Related]
6. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
7. The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells.
Balzeau J; Pinier M; Berges R; Saulnier P; Benoit JP; Eyer J
Biomaterials; 2013 Apr; 34(13):3381-9. PubMed ID: 23391494
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
9. The Neurofilament-Derived Peptide NFL-TBS.40-63 Targets Neural Stem Cells and Affects Their Properties.
Lépinoux-Chambaud C; Barreau K; Eyer J
Stem Cells Transl Med; 2016 Jul; 5(7):901-13. PubMed ID: 27177578
[TBL] [Abstract][Full Text] [Related]
10. Biological activity of gold nanoparticles combined with the NFL-TBS.40-63 peptide, or with other cell penetrating peptides, on rat glioblastoma cells.
Griveau A; Arib C; Spadavecchia J; Eyer J
Int J Pharm X; 2022 Dec; 4():100129. PubMed ID: 36164551
[TBL] [Abstract][Full Text] [Related]
11. Cell penetrating peptide decorated magnetic porous silicon nanorods for glioblastoma therapy and imaging.
Chaix A; Griveau A; Defforge T; Grimal V; Le Borgne B; Gautier G; Eyer J
RSC Adv; 2022 Apr; 12(19):11708-11714. PubMed ID: 35432942
[TBL] [Abstract][Full Text] [Related]
12. Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.
Salvati E; Re F; Sesana S; Cambianica I; Sancini G; Masserini M; Gregori M
Int J Nanomedicine; 2013; 8():1749-58. PubMed ID: 23674890
[TBL] [Abstract][Full Text] [Related]
13. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
15. Investigation on the self-assembly of the NFL-TBS.40-63 peptide and its interaction with gold nanoparticles as a delivery agent for glioblastoma.
Alnemeh-Al Ali H; Griveau A; Artzner F; Dupont A; Lautram N; Jourdain MA; Eyer J
Int J Pharm X; 2022 Dec; 4():100128. PubMed ID: 36204592
[TBL] [Abstract][Full Text] [Related]
16. The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2019 Jul; 566():218-228. PubMed ID: 31132447
[TBL] [Abstract][Full Text] [Related]
17. Characterization and quantification of the interaction between the NFL-TBS.40-63 peptide and lipid nanocapsules.
Griveau A; Alnemeh-Al Ali H; Jourdain MA; Dupont A; Eyer J
Int J Pharm X; 2022 Dec; 4():100127. PubMed ID: 36177093
[TBL] [Abstract][Full Text] [Related]
18. Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective.
Dong C; Yu X; Jin K; Qian J
Nanomedicine (Lond); 2023 Dec; 18(30):2161-2184. PubMed ID: 38180008
[TBL] [Abstract][Full Text] [Related]
19. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036
[TBL] [Abstract][Full Text] [Related]
20. Dual Functionalized 5-Fluorouracil Liposomes as Highly Efficient Nanomedicine for Glioblastoma Treatment as Assessed in an In Vitro Brain Tumor Model.
Lakkadwala S; Singh J
J Pharm Sci; 2018 Nov; 107(11):2902-2913. PubMed ID: 30055226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
